貝隆精密(301567.SZ):主要客户尚包括安費諾、三星電機、TDK、海康衞視、大華股份等
格隆匯1月17日丨有投資者於投資者互動平台向貝隆精密(301567.SZ)提問,“公開顯示,貴公司與舜宇光學建立了長期合作關係,而舜宇關係又是華為Mate60和蘋果iPhone15手機攝像頭的主力供應商,請問貴公司除向以上全球頭部手機生產商供貨外,還與哪些企業或領域提供產品?”,公司回覆稱,公司客户對於終端品牌有嚴格的保密要求。除手機領域外,公司在可穿戴設備(AR/VR)、汽車電子、智慧安居等應用領域均有產品佈局。除舜宇光學外,公司主要客户尚包括安費諾、三星電機、TDK、海康衞視、大華股份等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.